Jul 26, 2020 ... ... chemical restraint compared to visits without drug use (adjusted ... symptoms due to organic psychiatric disease or due to other drug use.

Jun 18, 2014 ... Substance use disorders among pregnant women continues to be a major public health concern, posing risk to the child's development, and imposing ...

Jan 22, 2010 ... As evidence emerges that complex gene alterations are involved in the onset of Parkinson's disease (PD), the role of environmental chemicals ...

May 10, 2023 ... Not surprisingly, many diseases that are considered autoimmune do not fully meet these criteria. In the absence of characteristic serological ...

Feb 15, 2017 ... This unprecedented compound has mainly been used in humans as an oral medication for treating filarial diseases but is also effective against ...

Aug 10, 2005 ... With the exception of psychomotor impairment and hyperkinesia, MA-induced movement disorders are not well documented in humans. This review ...

Dec 23, 2016 ... Introduction and Aims Even though individuals with substance-use disorders have a high prevalence of tobacco smoking, surprisingly little is ...

Jun 4, 2009 ... The review does not extend to the treatment of methamphetamine disorders. We will refer to amphetamine studies where evidence relating ...

Oct 9, 2024 ... ... symptoms and function state in representative SCZ and methamphetamine-induced psychotic disorder (MIP) patients. Then, we found seven ...

Jan 12, 2023 ... Known premortem medical conditions were none (N = 44), neurodegenerative disorder ... Metals transfer from tobacco to cigarette smoke: Evidences ...